This evaluation examined the effectiveness of the K-Four (Parema) high compression bandage system on 50 patients with recalcitrant 'hard-to-heal' venous leg ulcers and relates the outcome to an earlier randomised study which compared three other fourlayer bandage systems.
Results
The limb was only considered healed when all ulcers had healed; in other words, the researchers were concerned with the limb and not the healing of a reference ulcer. Healing rates were 53.2% at 12 weeks and 69.5% at 20 weeks. This is very much in line with expecta tions, given the shift in the change in the patient population and their higher mean score on the scoring system reported by Mar golis et al. 2 This product evaluation was conducted using the same withdrawal criteria as in the initial randomised study: any patient requir ing a period of treatment with reduced com pression was withdrawn, as were patients who were unable or unwilling to continue with this form of treatment.
Five patients were withdrawn during the evaluation but continued to receive com pression and four returned to an alternative fourlayer compression system (Charing Cross). This incidence of withdrawal (10%) is typical for high compression bandaging tri als. 5, 6 One patient died due to myocardial infarction; in this case the ulcer had almost healed (80% reduc tion in ulcer size). A further four patients ini tially reported that the new system was less comfortable than the previous bandage regi mens used within their clinic or community but these symptoms soon resolved and they chose to continue with the trial system.
The life curve for healing, taking into account the withdrawals, is given in Fig 1. Although no direct comparison can be made with the earlier study, no significant differ ence was noted between this and the earlier study groups when group comparisons were carried out.
Discussion
The trial bandage system produced accept able healing in this group of patients with proven recalcitrant ulcers. The change in referral practice which has followed the intro duction of local PACE guidelines, and which has been confirmed by local audit, has in turn resulted in a change in the clinic leg ulcer population, with a significant increase in the proportion of patients who have failed to heal with highcompression fourlayer bandaging in the community. This can be seen in the clinic's overall ulcer healing rate, The study findings indicated that there were no significant differences in the healing rates of the three systems.
1
This nonrandomised followup study was conducted at the request of the manufacturer (Parema) of a new bandage system, KFour, which consists of KSoft, KLite, KPlus and KoFlex, to establish its effectiveness in the treatment of venous ulceration.
Method
Fifty patients who had been referred to the Bradford Leg Ulcer Clinic were invited to take part in the study. The same recruitment criteria were used as in the previous study: 1 patients had to have a venous ulcer, an ankle brachial pressure index above 0.8, an ankle circumference of less than 25cm and be will ing to participate in the evaluation of this new product. Ethical committee approval was obtained before the study onset.
As this clinic acts as a tertiary referral cen tre, most patients had received compression therapy before entering the study. By defini tion most of the ulcers could be classed as 'hard to heal' as they were either recurrent, with a previous record of slow healing, or had been treated unsuccessfully elsewhere for a minimum of 12 weeks. This was confirmed by analysing the patient population using the criteria by Margolis et al., 2 which are based on a simple scoring system using ulcer size (greater than 5cm) and ulcer duration (more than six months). Applying the criteria by Margolis et al., in the initial study 1 62% of the patients had a score of 1 or above compared with 78% in the present one.
Four staff were responsible for applying the KFour bandages. All were trained in the application of fourlayer bandage systems and had regularly applied more than 50 ban dage systems per week.
The sample consisted of 32 men and 18 women with a mean age of 66.8 years (median: 67; SD: 13.42; range: 23-86). Twentyfour patients (48%) had multiple ulcers on the trial leg. The mean size of the largest ulcer on the study leg at recruitment was 5.67cm 2 (median: 3.125; SD: 6.26; range: 0.5-32). The mean duration of ulceration before recruitment was 205.3 weeks (median: 32; SD: 523.9; range: 2-2500).
Fourteen patients had a history of a deep vein thrombosis and 35 had recurrent ulcers. Based on the criteria used in the initial study, which has dropped from a mean of 62% at 12 weeks to 54% in the past year. At the same time there has been an increase in the mean ulcer size and prereferral ulcer duration, with most patients receiving at least three months of compression bandaging before referral, as well as overall ulcer duration. Taking into account the chronicity of the ulcers in the present study, the poor ankle and patient mobility and the ulcer size, these results are comparable with those obtained in the earlier randomised study, which com pared three alternative fourlayer regimens. As Nelson states, differences in bandaging techniques and patient characteristics may account for the variation in healing rates reported in bandaging trials.
8 Bandaging expertise and differences in patient popula tions are the most likely causes of the differ ences in treatment outcome. Differences between individual bandages within a four layer system are unlikely to have a major impact on treatment outcome as the specifi cation and characteristics of the bandages are very similar.
The data obtained in this product evalua tion and from our earlier study indicate that no system has an advantage over the others and that cost savings can be made by pursu ing a competitive purchasing policy without compromising patient outcome. 
Box 1. Summary of the main findings of the research study
This non-randomised study aimed to examine the effectiveness of the new K-Four bandage system by Parema on a sample of patients with recalcitrant 'hard-to-heal' venous leg ulcers Healing rates of 53% at 12 weeks and 70% at 20 weeks were achieved. Such rates would be expected for this patient population and are comparable with those obtained from an earlier randomised study by the same researchers which compared three alternative four-layer bandage systems
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